U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Vinill Inc. - 564925 - 02/28/2019
  1. Warning Letters

CLOSEOUT LETTER

Vinill Inc. MARCS-CMS 564925 —

Delivery Method:
United Parcel Service
Recipient:
Recipient Name
Leonid Kats
Recipient Title
Owner
Vinill Inc.

4801 2nd Ave
Brooklyn, NY 11232-4220
United States

Issuing Office:
Center for Food Safety and Applied Nutrition

United States

Dear Mr. Kats:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter [CMS 564925, September 21, 2018]. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustinability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implemnting regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude andy furture regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/s/
CDR Catherine M. Beer
Director of Compliance
Office of Human and Animal Food Operations
East - Division 1

Back to Top